Literature DB >> 22008130

[Circulating citrulline levels: a biomarker for intestinal functionality assessment].

Pascal Crenn1, Mouna Hanachi, Nathalie Neveux, Luc Cynober.   

Abstract

Circulating citrulline is emerging as an innovating biomarker candidate for assessment of intestinal function. Amino acid synthesized by enterocytes of intestinal mucosal, citrulline is not included in proteins or nutrition products and is a precursor for production of arginine by the kidney. Plasma citrulline is, in clinical situation, an established biomarker of enterocyte functional metabolic mass (trophicity) in children and in adult patients due to its high relation to active functional small bowel remnant length in intestinal diseases (short bowel, extensive enteropathies, intestinal toxicity of chemotherapy and radiotherapy. Plasma citrulline concentration (30-50  μmol/L), independent of nutritional status, if less than 10  μmol/L can give an objective threshold for nutrition parenteral use in case of intestinal failure due to enterocyte abnormalities or lack. Its regular dosage allows the monitoring of intestinal function except in case of significant renal failure.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22008130     DOI: 10.1684/abc.2011.0609

Source DB:  PubMed          Journal:  Ann Biol Clin (Paris)        ISSN: 0003-3898            Impact factor:   0.459


  8 in total

1.  Citrulline as a Biomarker for Gastrointestinal-Acute Radiation Syndrome: Species Differences and Experimental Condition Effects.

Authors:  K Bujold; M Hauer-Jensen; O Donini; A Rumage; D Hartman; H P Hendrickson; J Stamatopoulos; H Naraghi; M Pouliot; A Ascah; M Sebastian; M K Pugsley; K Wong; S Authier
Journal:  Radiat Res       Date:  2016-06-28       Impact factor: 2.841

2.  Long-term intermittent glutamine supplementation repairs intestinal damage (structure and functional mass) with advanced age: assessment with plasma citrulline in a rodent model.

Authors:  A M Beaufrère; N Neveux; P Patureau Mirand; C Buffière; G Marceau; V Sapin; L Cynober; D Meydinal-Denis
Journal:  J Nutr Health Aging       Date:  2014-11       Impact factor: 4.075

Review 3.  Glutamine metabolism in advanced age.

Authors:  Dominique Meynial-Denis
Journal:  Nutr Rev       Date:  2016-03-02       Impact factor: 7.110

4.  Screening and combining serum biomarkers to improve their diagnostic performance in the detection of intestinal barrier dysfunction in patients after major abdominal surgery.

Authors:  Can Kong; Shu-Min Li; Hua Yang; Wei-Dong Xiao; Yun-Yun Cen; Yi Wu; Wei-Ming Li; Da-Li Sun; Peng-Yuan Xu
Journal:  Ann Transl Med       Date:  2019-08

Review 5.  Proteins and amino acids are fundamental to optimal nutrition support in critically ill patients.

Authors:  Peter J M Weijs; Luc Cynober; Mark DeLegge; Georg Kreymann; Jan Wernerman; Robert R Wolfe
Journal:  Crit Care       Date:  2014-11-17       Impact factor: 9.097

6.  Identifying the etiology and pathophysiology underlying stunting and environmental enteropathy: study protocol of the AFRIBIOTA project.

Authors:  Pascale Vonaesch; Rindra Randremanana; Jean-Chrysostome Gody; Jean-Marc Collard; Tamara Giles-Vernick; Maria Doria; Inès Vigan-Womas; Pierre-Alain Rubbo; Aurélie Etienne; Emilson Jean Andriatahirintsoa; Nathalie Kapel; Eric Brown; Kelsey E Huus; Darragh Duffy; B Brett Finlay; Milena Hasan; Francis Allen Hunald; Annick Robinson; Alexandre Manirakiza; Laura Wegener-Parfrey; Muriel Vray; Philippe J Sansonetti
Journal:  BMC Pediatr       Date:  2018-07-19       Impact factor: 2.125

7.  Citrulline: just a biomarker or a conditionally essential amino acid and a pharmaconutrient in critically ill patients?

Authors:  Luc Cynober
Journal:  Crit Care       Date:  2013-03-11       Impact factor: 9.097

8.  Quantitative Metabolomic Analysis of Urinary Citrulline and Calcitroic Acid in Mice after Exposure to Various Types of Ionizing Radiation.

Authors:  Maryam Goudarzi; Siddheshwar Chauthe; Steven J Strawn; Waylon M Weber; David J Brenner; Albert J Fornace
Journal:  Int J Mol Sci       Date:  2016-05-20       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.